During the medical demo experience with Xyrem in narcolepsy/cataplexy sufferers at therapeutic doses, two patients described anxiety and one documented insomnia subsequent abrupt discontinuation for the termination from the medical demo; in The 2 individuals with anxiety, the frequency of cataplexy